Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Exanthema × ruxolitinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Primary Myelofibrosis 6 Myeloproliferative Disorders 6 Leukemia, Myeloid, Acute 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Myelodysplastic Syndromes 5 Thrombocythemia, Essential 4 Recurrence 4 Polycythemia Vera 4 Multiple Myeloma 4 Lymphoma, T-Cell, Cutaneous 3 Lymphoma, T-Cell 3 Leukemia 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Myelodysplastic-Myeloproliferative Diseases 2 Lymphoma, T-Cell, Peripheral 2 Lymphoma 2 Leukemia, Prolymphocytic, T-Cell 2 Leukemia, Myelomonocytic, Chronic 2 Leukemia, Large Granular Lymphocytic 2 Hematologic Neoplasms 2 Graft vs Host Disease 2 Carcinoma, Non-Small-Cell Lung 2 Triple Negative Breast Neoplasms 1 Targeted Therapy 1 Prostatic Neoplasms 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms 1 Neoplasm Metastasis 1 Mycosis Fungoides 1 Lymphoma, Non-Hodgkin 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06399029 2025-11-19

TRUX-LST

University of Zurich

Phase 2 Recruiting

Exanthema

Data powered by HemOnc (CC BY 4.0) Colophon ⚡